NovioSense said today that it closed a 4th financing round to support the upcoming clinical validation phase of its smartphone-based tear glucose sensor device. The round included existing investors such as Health Innovations, Fraunhofer Ventures and NovioTech, as well as 2 new U.S.-based investors, NovioSense said. The flexible, miniature tear glucose sensor rests on the lower eyelid […]
NovioSense
Major healthcare players form diabetes consortium
Four major players in healthcare said today they inked a collaborative partnership to develop a phone-based, low-cost diabetes platform for Type II patients worldwide. Gentag, Mayo Clinic, NovioSense and the Fraunhofer Institute for Microelectronic Circuits and Systems will partner for the consortium, combining their resources and over 75 issued patents for the development, the groups said. “By pooling […]
